InspireMD’s Healthy Q4 Masks Year-on-Year Sales Slide

InspireMD’s embolic protection stent has featured on several occasions on our pages. Newly released quarterly and year-end financials suggest it’s doing the job at sales level and anticipated clinical results should bolster future revenues.

InspireMD Reports Fourth Quarter and Fiscal Year 2013 Results (via PR Newswire)

BOSTON, Sept. 17, 2013 /PRNewswire/ — InspireMD Inc. (NYSE MKT: NSPR) (“InspireMD” or the “Company”), a leader in embolic protection stents, today announced financial results for its fourth quarter and fiscal year ended June 30, 2013. Key Highlights…

published: September 18, 2013 in: Cardio, Clinical Studies/Trials, Financial

Most read

Latest

^